跳至主要内容
临床试验/NCT01857011
NCT01857011已完成3 期

Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty: a Randomized Controlled Trial

Federal University of São Paulo1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2014年4月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
56
试验地点
1
主要终点
Hemoglobin level

研究概览

简要总结

The purpose of this study is to determine whether intravenous or oral iron are effective in the treatment of postoperative anemia and iron deficiency in patients submitted in postbariatric abdominoplasty.

详细描述

Multicenter open randomized clinical trial with allocation ratio 1: 1. 56 adult patients undergoing post- bariatric abdominoplasty will be evaluated. The study group will receive 200 mg of intravenous iron in the immediate postoperative period and a second application on day 1 postoperatively. The control group will receive 100 mg of oral iron twice daily for 8 weeks. Haematological variables , iron 's profile , quality of life ( SF -36 and FACT- An) and adverse events will be assessed preoperatively and on the first , fourth and eighth weeks postoperatively .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18 a 55 years
  • Prior open or laparoscopic standard limb Roux and Y gastric bypass
  • BMI < 32 kg/m2
  • Stability of weight loss for at least 6 months
  • grade 3 abdominal deformity on the Pittsburgh scale

排除标准

  • Illiterate
  • Current smoking
  • Prior IV iron use in the last 3 months
  • Uncontrolled systemic diseases
  • Hemoglobin < 11 g/dL
  • Ferritin <11 ng/mL
  • Ferritin > 100 ng/mL
  • transferrin saturation <16%
  • transferrin saturation> 50%
  • B12 < 210 pg/mL
  • Folic Acid < 3.3 ng/mL
  • Albumin < 2 g/dL
  • C reactive protein> 5 mg/L
  • Prior Anaphylactic reaction to IV iron

研究组 & 干预措施

IV Iron

Experimental

Intravenous Iron Sucrose 200 mg in the immediate postoperative period and first day postop.

干预措施: Intravenous Iron sucrose (Drug)

Oral Iron

Active Comparator

Oral iron(III)-hydroxide polymaltose complex 100 mg twice daily in the fist 8 postoperative weeks.

干预措施: Oral Iron (Drug)

结局指标

主要结局

Hemoglobin level

时间窗: 8 postoperative weeks

Hemoglobin level measured at 8 postoperative weeks

次要结局

  • Ferritin levels(Preoperative (one day before surgery) and 1, 4 and 8 postoperative weeks)
  • FACIT(Preoperative (one day before surgery) and 1, 4 and 8 postoperative weeks)
  • SF36(Preoperative (one day before surgery) and 1, 4 and 8 postoperative weeks)
  • Transferrin saturation(Preoperative (one day before surgery) and 1, 4 and 8 postoperative weeks)
  • Hemoglobin levels(preoperative (one day before surgery) and 1, 4 postoperative weeks)

研究者

发起方
Federal University of São Paulo
申办方类型
Other
责任方
Principal Investigator
主要研究者

Juan Carlos Montano Pedroso

MD

Federal University of São Paulo

研究点 (1)

Loading locations...

相似试验